A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

ProgenaBiome

Status

Unknown

Conditions

Mesothelioma; Lung

Mesothelioma Peritoneum

Mesothelioma; Liver

Mesothelioma Malignant

Mesothelioma

Mesothelioma; Omentum

Mesotheliomas Pleural

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

PRG-035

Details and patient eligibility

About

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Full description

The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to Metastatic Mesothelioma

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study

a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
Male or female of all ages. (interest is given to children who present with autism or Crohn's and whose parents wish to analyze their children's gut flora. Also of interest analysis of development of the child's microbiome. In the case of autism, the younger the child, the better to correct the neurological problems if an association is found between autism and the microbiome)
Diagnosis of metastatic mesothelioma through biopsy and/or advanced imaging

Exclusion criteria

Refusal to sign informed consent form
History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
Postoperative stoma, ostomy, or ileoanal pouch
Participation in any experimental drug protocol within the past 12 weeks
Treatment with total parenteral nutrition